NOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.
Rejuvenate and ABG II hip implants were called off the market by Stryker Corporation in July 2012. The move came after the receipt of various complaints by the FDA (Food and Drugs Administration USA) regarding these two models. The patients who received these implants have developed various ailments including severe pain, swelling and disability.